Table IV.
Clinicopathological characteristics of HRD discordant cases.
| GIS score Myriad | GSS score Amoy | Histotype | Age at diagnosis | Family history | FIGO stage | Surgery | Residual tumor | NACT | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 22 | 58.2 | HGSOC | 40-45 | No | IIIC | IDS | Yes * | Yes |
| 2 | 29 | 51.7 | HGSOC | 65-70 | Yes | IVB | PCS | No | No |
| 3 | 14 | 84.8 | HGSOC | 55-60 | No | IIIC | IDS | No | Yes |
| 4 | 40 | 85.1 | HGSOC | 55-60 | No | IVB | PCS | Yes * | No |
| 5 | 32 | 64.1 | HGSOC | 50-55 | No | IVB | PCS | No | No |
| 6 | 22 | 52.9 | HGSOC | 65-70 | Yes | IIIC | PCS | No | No |
| 7 | 23 | 56.1 | HGSOC | 60-65 | No | IIIC | PCS | No | No |
| 8 | 23 | 90.4 | HGSOC | 60-65 | Yes | IIIC | IDS | Yes * | Yes |
| 9 | 39 | 62.5 | HGSOC | 65-70 | Yes | IIIC | IDS | No | Yes |
* ≤ 0.5 cm.
HGSOC: High grade serous carcinoma; IDS: interval debulking surgery; PCS: primary cytoreductive surgery; NACT = neoadjuvant chemotherapy.